Oxygen Toxicity, Respiratory Failure
Conditions
Brief summary
The investigators recently evaluated 4 different oximeters among the most commonly used with arterial catheter in place and compared SpO2 with SaO2 obtained on arterial gas. Correlations between SaO2 and SpO2 were poor for all oximeters, as previously known, and SpO2-SaO2 bias were different between oximeters. Some oximeters (Masimo, Nellcor) had lower biases but they detected less well hypoxemia. Some oximeters underestimated SaO2 (Nonin) but detected very well hypoxemia, and some overestimated SaO2 (Philips). The investigators concluded that oximeters provide different informations to clinicians, and oxygenation targets should take into account for these differences. The assumption is that the SpO2 target AND oximeter used will both have an impact on oxygen flows and that these effects will add up. With a high SpO2 target, oxygen flows will be significantly greater and with the Nonin oximeter, the required flows will be greater than with the Philips oximeter. NB: the results obtained were in a population with light skin pigmentation (96% of the patients were Fitzpatrick 1-2, reflecting the local hospitalized population).
Detailed description
The oximeters to be evaluated will be the Nonin (Plymouth, MN), and the Philips (Eindhoven, Netherlands). The sensors used will be digital reusable sensors for all oximeters. Because of the impact of the fingers used for SpO2 measurement, each oximeter will be randomly assigned a different finger to each patient (digit 2 and 3 on the hand opposite to the arterial catheter). Two SpO2 targets will be assessed: 90% and 94%. A total of four 10-minute periods will be performed in randomized order: Nonin 90, Nonin 94, Philips 90, and Philips 94. At the end of each 10-minute period, arterial gas will be collected through the arterial catheter. The adjustment of the oxygen flow rates will be performed manually. The average oxygen flow of the last 2 minutes of the period will be considered.
Interventions
DEVICEManual Oxygen titration with Philips oximeter (SpO2 target 90%)
Oxygen titration with FreeO2 device (fixed flow mode) to reach the SpO2 target (set at 90%) with Philips oximeter
DEVICEManual oxygen titration with Nonin oximeter (SpO2 target 90%)
Oxygen titration with FreeO2 device (fixed flow mode) to reach the SpO2 target (set at 90%) with Nonin oximeter
DEVICEManual Oxygen titration with Philips oximeter (SpO2 target 94%)
Oxygen titration with FreeO2 device (fixed flow mode) to reach the SpO2 target (set at 94%) with Philips oximeter
DEVICEManual oxygen titration with Nonin oximeter (SpO2 target 94%)
Oxygen titration with FreeO2 device (fixed flow mode) to reach the SpO2 target (set at 94%) with Philips oximeter
Sponsors
Laval University
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* ≥ 18 years of age * Patients admitted to postoperative cardiac surgery intensive care unit * Presence of an arterial catheter Specific for the extubate patient * Ongoing on conventional oxygen therapy at moderate flow (up to a maximum of 5L/min) with SpO2 between 88 and 100% with the usual oximeter and nasal cannula. * SpO2 \< 92% ambient air Specific for the intubate patient FiO2 \<= 0.60 with SpO2 between 88 and 100% with usual oximeter SpO2 \< 92% with FiO2 0.21
Exclusion criteria
* No SpO2 signal with oximeter in use * False nails or nail polish * Methemoglobinemia \>0.015 on last available arterial gas * Patient in isolation (multi-resistant bacteria, C-Difficile, SARS-CoV-2 ...) Specific for the extubate patient * Expected to use another respiratory support within one hour of inclusion (NIV or nasal high flow oxygen) Planned extubation within one hour of inclusion
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Oxygen flow (or FiO2) | Mean Oxygen flow in the two last minute of each study period (between minute 8 and 10) | Oxygen flows (or FiO2) at the end of each study period (last minute average) to reach SpO2 target to reach SpO2 target with specific oximeter |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Difference between SpO2 and SaO2 | assessed up to 10 minutes - at the same of the arterial blood gases punction | Difference (%) between SpO2 from each oximeter and SaO2 (% of SaO2 overestimation and underestimation for each oximeter) |
Other
| Measure | Time frame | Description |
|---|---|---|
| Occult hyperoxemia | assessed up to 10 minutes - at the same of the arterial blood gases punction | Perrcentage of occult hyperoxemia (SaO2\>96% and SpO2\<=96%) |
| Partial oxygen weaning | Mean oxygen flow in the two last minute of each study period (between minute 8 and 10) | Rate of partial oxygen weaning (Oxygen flow \<=0.5 L/min) |
| Mean difference on oxymeter | assessed up to 10 minutes - at the same of the arterial blood gases punction | Mean (±SD) of the gaps between the different oximeters tested |
| Respiratory support escalation | Mean oxygen flow in the two last minute of each study period (between minute 8 and 10) | Indication of initiation of respiratory support escalation (Oxygen flow \>6 L/min or FiO2 \> 0.60) |
| Complete oxygen weaning | Mean oxygen flow in the two last minute of each study period (between minute 8 and 10) | Rate of complete oxygen weaning (Oxygen flow =0 L/min or FiO2 0.21) |
| Occult hypoxemia | assessed up to 10 minutes - at the same of the arterial blood gases punction | Percentage of occult hypoxemia (SaO2\<90% and SpO2\>=90%) |
Countries
Canada
Contacts
Primary ContactFrancois Lellouche
Backup ContactPierre Alexandre Bouchard
Outcome results
None listed